2-(N-ISOBUTYL-3,5-DIMETHYLISOXAZOLE-4-SULFONAMIDO)ACETIC ACID, 95.0%, 250mg

6-(3-chlorophenyl)-6-oxohexanenitrile, 97.0%, 2g

ETHYL 2-(2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETATE, 95.0%, 250mg

Cacothéline, >=95%, pa, 10 g, emballage en verre

trans-Cyclohexane-1,4-dicarboxylic acid, 95.0%, 100g

2-Bromofuran-3-carboxylic acid, 97%, 250mg

(4-BROMO-1H-PYRAZOL-5-YL)METHANOL, 1g

Na-Acetyl-L-lysine methyl amide, 95.0%, 1g

1,2-BIS(4-METHOXYPHENYL)ETHANONE, 97.0%, 1g

Ethyl 2-amino-4-methylpent-4-enoate heminaphthalene-1,5-disulfonate, 98%, 5g

trans-2-Pentenal, 95.0%, 475g

[2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methoxyphenyl]boronic acid hydrochloride, 95.0%, 1g

Perfluoropropoxyethylene>98.0%(GC)10g